Determination of metanephrine (MN), normetanephrine (NMN) and 3-methoxytyramine (3-MT) in saliva could be of diagnostic value in patients with pheochromocytoma. This preliminary study was set out to determine metanephrine concentrations in saliva from healthy subjects compared to their simultaneously measured plasma levels. In addition, we studied the possible influence of pre-analytical conditions such as a collection device, awakening, position, and eating on the salivary metanephrine levels. We included 11 healthy volunteers. Fasting blood and saliva samples were collected in seated position and after 30 minutes of horizontal rest. Saliva samples 30 minutes after eating were also collected. Saliva was collected with and without the use of a polyethylene salivette. Plasma and salivary MN, NMN and 3-MT concentrations were determined using a High-Performance Liquid Chromatography tandem mass spectrometric technique (LC-MS/MS) with automated solid phase extraction sample preparation. Metanephrines were detectable in saliva from all participants both in seated and the supine position. We found no significant correlation between the MN, NMN and 3-MT concentrations in saliva and plasma in the seated or supine position. In addition, there was no difference between MN, NMN and 3-MT concentrations collected with or without a collection device. Plasma MN, NMN, 3-MT and salivary NMN concentrations collected in seated position were significantly higher compared concentrations of samples collected in supine position (all P<.05). In conclusion, salivary metanephrines can be detected with LC-MS/MS with sufficient sensitivity and precision. Our findings warrant evaluation of salivary metanephrine measurement in the work-up of patients who are suspected to harbor pheochromocytoma.